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Sleep^wake disturbances (SWD) are common after traumatic brain injury (TBI). In acuteTBI, we recently found
decreased CSF levels of hypocretin-1, a wake-promoting neurotransmitter. In the present study, we aimed to
delineate the frequency and clinical characteristics of post-traumatic SWD, to assess CSF hypocretin-1 levels
6 months afterTBI, and to identify risk factors for posttraumatic SWD. A total of 96 consecutive patients were
enrolled within the first 4 days afterTBI. Six months later, out of 76 TBI patients, who did not die and who did
not move to foreign countries, we included 65 patients (86%, 53 males, mean age 39 years) in our study. Patients
were examined using interviews, questionnaires, clinical examinations, computed tomography of the brain,
laboratory tests (including CSF hypocretin-1 levels, and HLA typing), conventional polysomnography, mainte-
nance of wakefulness andmultiple sleep latency tests (MSLT) and actigraphy. Potential causes of post-traumatic
SWD were assessed according to international criteria. New-onset sleep^wake disturbances followingTBI were
found in 47 patients (72%): subjective excessive daytime sleepiness (EDS; defined by the Epworth Sleepiness
Scale 10) was found in 18 (28%), objective EDS (as defined by mean sleep latency 55min on MSLT) in
16 (25%), fatigue (daytime tiredness without signs of subjective or objective EDS) in 11 (17%), post-traumatic
hypersomnia ‘sensu strictu’ (increased sleep need of 2 h per 24h compared to pre-TBI) in 14 (22%) patients
and insomnia in 3 patients (5%). In 28 patients (43% of the study population), we could not identify a specific
cause of the post-traumatic SWD other thanTBI. Low CSF hypocretin-1 levels were found in 4 of 21 patients 6
months afterTBI, as compared to 25 of 27 patients in the first days afterTBI.Hypocretin levels 6 months after
TBIwere significantly lower in patients with post-traumatic EDS.Therewere no associations between post-trau-
matic SWD and severity or localization of TBI, general clinical outcome, gender, pathological neurological find-
ings and HLA typing. However, post-traumatic SWD correlated with impaired quality of life. These results
suggest that sleep^wake disturbances, particularly EDS, fatigue and hypersomnia are common after TBI, and
significantly impair quality of life. In almost one out of two patients, post-traumatic SWD appear to be directly
related to the TBI. An involvement of the hypocretin system in the pathophysiology of post-traumatic SWD
appears possible. Other risk factors predisposing towards the development of post-traumatic SWD were not
identified.
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Introduction
Post-traumatic sleep–wake disturbances (SWD) such as
insomnia, hypersomnia ‘sensu strictu’ (defined as increased
sleep need per 24 h), and excessive daytime sleepiness (EDS)
are common in clinical practice (Rao, 2002; Cohen et al.,
1992). However, only a few, mostly retrospective studies
have examined SWD after traumatic brain injury (TBI).
Insomnia
In their prospective study based on sleep questionnaires,
Fichtenberg and collaborators (2002) found a high
prevalence (30%) of insomnia and poor sleep quality in
50 patients after TBI. In a retrospective study comprising a
heterogeneous population of 184 somnolent subjects suffer-
ing from TBI or head–neck trauma (whiplash injury),
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45% of the patients reported insomnia (‘disturbed noctur-
nal sleep’), mostly due to nocturnal pain (Guilleminault
et al., 2000). A recent study examined sleep–wake diaries of
63 TBI patients and 63 healthy controls; the authors found
an increased number of night-time awakenings and higher
sleep onset latencies in TBI patients, particularly in those
with mild injuries, anxiety and depression (Parcell et al.,
2006). Insomnia has been shown to persist 3 years after TBI
(Kaufman et al., 2001).
In a questionnaire study by Ouellet and colleagues
(2006a), more than 50% of 452 TBI patients reported
insomnia symptoms, and insomnia was a severe and
chronic condition remaining untreated in almost 60% of
cases. The authors explained this high prevalence by clinical
characteristics associated with insomnia symptoms such as
higher levels of fatigue, depression and pain. In the same
direction, 14 TBI patients were compared to 14 healthy
good sleepers by the same group, and all subjective
measures of sleep as assessed by questionnaires revealed
significant sleep disturbances in the TBI group (Ouellet
et al., 2006b). The authors found, however, that TBI
patients with insomnia have a tendency to overestimate
their sleep disturbance compared to polysomnographic
measures of sleep. Together, these studies, which are based
on subjective reports from patients, suggested that insomnia
may be common but overestimated after TBI.
Fatigue, hypersomnia and EDS
Fatigue as assessed by validated scales appears to be
common among patients with TBI (LaChapelle and
Finlayson, 1998). Also using questionnaires, Stulemeijer
and collaborators (2006) observed fatigue in one out of
three patients 6 months after mild TBI. Furthermore, they
found a clear negative impact of fatigue on quality of life.
In a recent review, Belmont and collaborators (2006)
summarized that post-traumatic fatigue is common,
independent of TBI severity, and may be related to
insufficiency in the hypothalamic-pituitary axis. Masel and
colleagues (2001) found EDS (defined as abnormally low
mean sleep latencies in multiple sleep latency tests, MSLT)
in almost half (33 of 71) of their patients described as
having different types of brain injury (traumatic, ischaemic,
haemorrhagic, anoxic). In 21 patients (30%), ‘post-traumatic
hypersomnia’ (defined as EDS in the absence of narcoleptic
symptoms, pathological sleep apnea or periodic limb move-
ment indices) was diagnosed. Latency between onset of
TBI and sleep recordings, however, varied considerably
between subjects. Furthermore, 49 patients were on medica-
tion at the time of the study; laboratory examinations aimed at
ruling out other reasons for sleepiness were not performed.
On the other hand, Castriotta and co-workers performed
polysomnography andMSLT in 10 patients with TBI and EDS
and found sleep–wake disorders such as sleep apnea and
periodic limb movement syndrome in all tested patients
(Castriotta et al., 2001). In a retrospective study comprising
20 patients with post-traumatic EDS and based on sleep
questionnaires and electrophysiological examinations (poly-
somnography, MSLT), eight subjects were found to suffer
from sleep apnea syndrome (Guilleminault et al., 1983).
In summary, fatigue, hypersomnia and EDS have been
reported to be frequent after TBI. Retrospective assessments
and methodological shortcomings of previous studies,
however, make it impossible to draw clinical relevant
conclusions.
Circadian sleep^wake disorders
The findings pertaining to circadian sleep–wake disorders
are also rather inconclusive. Anecdotal reports on a post-
traumatic delayed sleep phase syndrome have been
published, but a recent study of 10 patients failed
to provide evidence of any shift in circadian timing
of sleep subsequent to TBI (Quinto et al., 2000;
Steele et al., 2005).
The neurobiological bases for post-traumatic SWD are
unknown. In a recent study, we found significantly
decreased CSF hypocretin-1 levels in patients with acute
TBI (Baumann et al., 2005). Since this hypothalamic
neuropeptide is involved in sleep–wake regulation
(Nishino et al., 2000), it is reasonable to assume that
hypocretin neurotransmitter deficiency could contribute to
the pathophysiology of post-traumatic SWD.
In summary, the frequency and characteristics of post-
traumatic SWD have not been systematically examined in
spite of their high prevalence and their medical, social,
economic and medicolegal implications. The primary aim
of this study was to assess frequency, clinical characteristics
and causes of sleep–wake disorders after TBI. Secondly,
we sought to identify risk factors as well as parameters
prognostic for the development of post-traumatic SWD.
Third, we tested whether hypocretin deficiency might be
associated with post-traumatic SWD.
Material and Methods
The protocol for this prospective study was approved by the ethics
committee of the University Hospital of Zurich.
Patients
The study comprised 96 consecutive patients (75 males, mean
age SD 38 16 years, range 16–72) with acute, first-ever TBI,
admitted to our hospital between July 2003 and June 2006
immediately after the injury. Patients with sleep–wake and/or
psychiatric disorders diagnosed prior to TBI were excluded.
Informed consent for study participation was obtained from all
patients before participation (in comatose patients after regaining
of the consciousness). For the execution of a lumbar puncture,
additional written informed consent was mandatory.
Definitions
Sleep–wake disorders and symptoms were identified by the
means of interviews, questionnaires and sleep studies (Table 1).
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Specific sleep–wake disorders were diagnosed according to the
international criteria (American Academy of Sleep Medicine,
2005).
Severity of TBI
Severity of TBI was assessed (i) clinically using the Glasgow
Coma Scale (13–15¼mild, 9–12¼moderate and 3–8¼ severe)
and (ii) by cerebral computed tomography (CT) using
the Marshall criteria (I¼ no visible intracranial pathology,
II–IV¼midline shift and V¼mass lesion) (Marshall et al., 1992).
Clinical outcome 6 months afterTBI
Six months after TBI, patients were examined by the first author.
The interview comprised questions about social status and
residual symptoms since TBI. Thereafter, patients were given a
comprehensive neurological examination. Neuropsychological
functions were assessed using a standardized protocol that
tapped verbal and visuospatial memory functions and fluency,
speed of information processing and the affective state; the
Folstein Mini-Mental State Examination was part of the protocol
(Schmidgen et al., 1994). Outcome was classified according to
the Glasgow Outcome Scale (GOS; 1¼ dead, 2¼ vegetative
state, 3¼ severe disability, 4¼moderate disability and 5¼ good
recovery). To detect depression, all patients were given the
Beck Depression Inventory, a self-report rating inventory
measuring characteristic symptoms and severity of depression
(Beck et al., 1961).
We assessed quality of life using the SF-36, a questionnaire
aimed at capturing the relative impact of disease on physical and
social functioning, role activities due to physical/emotional
functioning, bodily pain, vitality (energy and fatigue), mental
health and general health perception (Findler et al., 2001).
SWD 6 months afterTBI: interviews and
questionnaires
During the interviews, we assessed changes in sleep habits, sleep
quality, daytime vigilance (e.g. do you feel tired/sleepy during the
day since TBI?) and insomnia symptoms. All patients filled out
an extensive sleep questionnaire that comprised validated scales
such as the Epworth Sleepiness Scale (ESS; 10 suggests EDS)
(Johns, 1991), the Sleep Apnea Scale of the Sleep Disorders
Questionnaire (SA-SDQ 32 for females or 36 for males
suggests sleep-related breathing disorders) (Douglass et al., 1994),
the Ullanlinna Narcolepsy Scale (14 suggests narcolepsy)
(Hublin et al., 1994) and the Swiss Narcolepsy Scale (50 suggests
narcolepsy) (Sturzenegger and Bassetti, 2004).
SWD 6 months afterTBI: sleep studies
Conventional overnight polysomnography (PSG, using a
16-channel recording system: Embla A10) was performed from
11 p.m. to 7 a.m. Sleep-stage scoring was performed visually by the
first author according to standard criteria (Rechtschaffen and
Kales, 1968). PSG was followed by a modified Maintenance
of Wakefulness Test (MWT; one single test at 8 a.m., measuring
the ability to stay awake for 20min while sitting quietly in a
dark room) and subsequently by a Multiple Sleep Latency Test
(MSLT; 4–5 sleep opportunities every 2 h, objectively measuring
EDS under standard conditions in the absence of external alerting
factors) (Littner et al., 2005). Mean sleep latency in the MWT and
the MSLT was defined as the time from light-off to the first epoch
of any sleep stage. A drug washout for 10 days prior to recordings
was performed in all patients.
In 27 patients, sleep and physical activity levels were
recorded over 14 days with sleep logs, and verified with wrist
actigraphy (on the non-dominant wrist; light sensor data included,
Actiwatch, Neurotechnology) (King et al., 2005). With this
software the determination of ‘time asleep’ and ‘time awake’
relies on an algorithm using the activity data recorded by the
Actiwatch in a series of linked calculations.
Laboratory studies
Within the first 4 days after TBI, whenever possible, we measured
hypocretin-1 levels in CSF, obtained by intraventricular catheters,
inserted for continuous intracranial pressure monitoring, or by
lumbar puncture (n¼ 27, contaminated with blood in five
patients) (Baumann et al., 2005). Six months after TBI, we
determined CSF hypocretin-1 determinations in a subset of
patients (n¼ 21) who gave informed consent to undergo
a lumbar puncture. Hypocretin-1 levels below 320 pg/ml
Table 1 Definitions of sleep^wake disturbances and symptoms in this study
Sleep^wake disturbance/symptom Definition
Subjective excessive daytime sleepiness S-EDS Epworth Sleepiness Scale (ESS) 10
Objective excessive daytime sleepiness O-EDS Mean sleep latency on multiple sleep latency
test (MSLT)55min
Sleep attacks Involuntary, short episodes of unwanted sleep
Post-traumatic hypersomnia PH Increased sleep need per 24h (at least 2 h more
than beforeTBI)
Fatigue Tiredness reported at interview, ESS510 and mean
sleep latency on MSLT410min
Insomnia Chronic inability to fall or remain asleep for an
adequate length of time at night, associated with
daytime tiredness
Behaviourally induced insufficiency
sleep syndrome
BIISS Difference in sleep time per 24h between weekdays
and weekends/holidays 2h
Note: Specific sleep disorders such as narcolepsy, obstructive sleep apnea syndrome or restless legs syndrome, were diagnosed according to
the international criteria (American Academy of Sleep Medicine, 2005).
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are considered low (detection limit at 40 pg/ml) (Baumann et al.,
2004).
Serum laboratory tests 6 months after TBI included haemoglo-
bin levels, parameters of thyroid function and iron metabolism.
HLA typing was performed to detect narcolepsy-associated alleles.
Post-traumatic SWD: identification of potential
causes and of risk factors
In all patients with post-traumatic SWD, we searched for the
presence of underlying causes such as specific sleep–wake
disorders (e.g. sleep-related breathing or movement disorders,
narcolepsy or behaviourally induced insufficiency sleep syndrome),
or the presence of other sleep-modifying disorders including
substance abuse. Furthermore, we examined whether demo-
graphic, residual clinical symptoms or TBI characteristics were
associated with post-traumatic SWD.
Statistical analyses
Statistical analyses were performed by correlation analyses
(Pearson and Spearman), Student’s t-tests, Mann–Whitney
U-tests, Chi-square tests and multivariate regression analyses.
Results
Patients
Fifteen out of the 96 patients (16%) died (GOS 1) within
the first 4 weeks after injury (moderate TBI in 3, severe TBI
in 12). Five of the surviving 81 patients were abroad 6
months after the injury (TBI mild in 3, moderate in 1,
severe in 1; GOS not available), and 11 patients refused to
participate in the follow-up (TBI mild in 6, moderate in 2,
severe in 3; GOS 5 in 7, GOS 4 in 4). Sixty-five patients
participated in the present study (86% of 76 patients who
did not die and who did not move to foreign countries; 53
males, 12 females, mean age 39 years, range 16–72).
Severity of TBI
TBI was mild in 26 (40%), moderate in 15 (23%) and
severe in 24 (37%) patients (Fig. 1). Median GCS was 11
(mean 10.2, range 3–15). Twenty-five patients (38%)
sustained an injury to multiple organs. Lesions on brain
CT scans were observed in frontal (n¼ 29, 45%), parietal
(n¼ 19, 29%), temporal (n¼ 24, 37%), occipital (n¼ 18,
28%) and in brainstem/midbrain (n¼ 10, 15%) locations.
Brain CT was normal (Marshall I) in 21 (32%) patients.
Intracranial haemorrhage was found in 34 (52%) patients
(subarachnoidal haemorrhage in 14 patients).
Clinical outcome 6 months afterTBI
187 17 days after TBI, outcome was ‘good’ in 31,
‘moderate disability’ prevailed in 30 and ‘severe disability’
in 4 patients (GOS; median 4, mean 4.4, range 3–5; Fig. 1).
Twenty-eight (43%) patients reported subjective memory
impairment after TBI, and 26 (40%) concentration
problems. Increased headache compared to pre-TBI state
was reported by 15 (23%) patients.
Pathological findings in the neurological examination
were found in 36 (55%) patients. The most common
pathologies were cranial nerve dysfunctions (n¼ 19, 29%),
loss of sensation (n¼ 9, 14%) and limb paresis (n¼ 9,
14%). Memory functions were objectively impaired in six
patients. In the Mini-Mental Status Examination, a mean
score of 29 points was achieved (median 30, range 24–30,
527 in five patients).
On the Beck Depression Inventory, six patients qualified
for mild to moderate depression, and two patients for
moderate to severe depression.
Fifty-four patients resumed work. In evaluating the
quality of life by the SF-36 questionnaire the lowest
scores (most severe problems; maximum: 100) were found
with respect to vitality (60.3 18.9) and general health
perception (61.7 25.1). The highest scores (least pro-
blems) were obtained with respect to bodily pain
(87.6 20.6).
SWD 6 months afterTBI: interviews and
questionnaires
Post-traumatic hypersomnia was diagnosed in 14 patients
(22%), and insomnia in three patients (5%). Two (3%)
patients reported sleep attacks. Mean time spent in bed per
24 h was 8.0 1.5 h (median: 8, range 6–14 h). Regular
(3/week) daytime naps were reported by 12 patients
(18%). Symptoms suggestive of circadian sleep–wake
disorders such as advanced/delayed sleep phase syndrome
were not reported during interviews. Cataplexy-like events
were reported by one (2%) patient, but they did not fulfill
the criteria of definite cataplexy (Anic-Labat et al., 1999;
Bassetti et al., 2003). Sleep paralysis was reported by three
(5%) and hypnagogic hallucinations by three (5%) patients.
New parasomnias after TBI were not reported. Sleeping
pills were taken regularly by four patients, antidepressants
by seven patients.
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Fig. 1 Though many patients had a moderate or severeTBI,
clinical outcomes were generally good.TBI severity in the acute
phase (as assessed by the Glasgow Coma Scale; left side), and
general outcome (as assessed by the Glasgow Outcome Scale;
right side) 6 months afterTBI (right side).
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Mean ESS 6 months after TBI was 7.5 (median 6.5, range
2–20). Subjective EDS (S-EDS) defined as ESS  10 was
found in 18 (28%) patients. ESS was 14 in 5 (8%)
patients. The mean Ullanlinna Narcolepsy Scale score was
5.0 (range 0–18), and 14 in 3 patients. Swiss Narcolepsy
Scale values were normal in all patients. Mean SA-SDQ
score was 24.4 (range 16–49), 36 in 8 (15%) male patients
and 32 in one (8%) female patient. The mean body mass
index was 24.0 (range 18–35).
SWD 6 months afterTBI: sleep studies
Sleep efficiency in PSG was below age-adjusted 25%
percentile values in three patients (mild TBI: n¼ 2, severe
TBI: n¼ 1) (Danker-Hopfe et al., 2005) (Table 2). On
modified MWT, 15 patients fell asleep. On MSLT, objective
EDS (O-EDS; mean sleep latency55min) was found in 16
(25%) patients. There was no significant correlation
between mean sleep latency on MSLT and ESS. S-EDS
and/or O-EDS were found in 25 patients (38%); the
concurrence of both S-EDS and O-EDS was found in 9
patients. Fatigue was diagnosed in 11 patients (Fig. 2). In 8
PH patients, post-traumatic hypersomnia was not asso-
ciated with fatigue or EDS.
Actigraphy monitoring and sleep logs documented
an increased mean time ‘asleep’, i.e. 9 h per 24 h, in
14 of 27 (52%) patients. There were no correlations
between mean time ‘asleep’ and measures of excessive
daytime sleepiness (ESS, MSL on MSLT), fatigue
(by history) or depression (Beck Depression Inventory).
Actigraphy and sleep logs did not reveal circadian sleep
disorders in any patient.
Table 2 Polysomnography, MSLTand MWT findings in 65 patients at 6 months afterTBI
Mild TBI (n¼ 26) ModerateTBI (n¼15) SevereTBI (n¼ 24) All TBI (n¼ 65) P
Demographics and TBI
Age 4015 4419 3618 3917 0.34
Male gender 22 (85%) 10 (67%) 21 (88%) 53 (82%) 0.32
GOS# 5 (5, 4^5) 4 (4, 3^5) 4 (4, 3^5) 4 (4, 3^5) 0.60
Polysomnography
Sleep efficiency (%) 92 6 918 8811 919 0.21
Sleep latency (minutes) 1513 2316 2119 1916 0.27
Sleep-onset REM period 3/26 1/15 3/24 7/65 0.23
Mean arousal index 9 7 810 8 6 9 6 0.95
AHI (per hour) 612 714 4 7 511 0.74
AHI410 3/26 1/15 3/24 7/65 0.88
PLMI (per hour) 610 4 8 59 59 0.71
PLMI415 2/26 1/15 3/24 6/65 0.72
REM sleep (%) 20 8 195 20 5 20 6 0.79
NREM I sleep (%) 12 6 10 8 115 116 0.74
NREM II sleep (%) 4910 47 9 417 459 0.02
NREM III/IV (%) 159 1710 17 9 169 0.62
MSLT
Mean sleep latency (minutes) 8 5 10 4 10 5 95 0.30
Mean sleep latency55min 9/26 2/15 5/24 16/65 0.23
2 Sleep-onset REM periods 3/26 1/15 2/24 6/65 0.81
MWT
Mean sleep latency (minutes) 15 4 1311 12 6 135 0.70
NREM I achieved 7/26 2/15 6/24 15/65 0.78
NREM II achieved 1/26 0/15 2/24 3/65 0.37
Note: GOS: Glasgow Outcome Scale; PLMI: periodic limb movement index; AHI: apnea-hypopnea-index; : mean SD; #: mean, median,
range.
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Fig. 2 Low or undetectable CSF hypocretin levels were observed
in most patients in the acute phase of TBI, but levels increased
to low and normal levels 6 months later. Cerebrospinal (CSF)
hypocretin-1 levels in 27 patients with acuteTBI (left side), and in
21 patients 6 months afterTBI (right side). Lines connect hypocre-
tin values from the same patient (n¼15). The dotted horizontal
line indicates the border between normal and low hypocretin
levels. Undetectable hypocretin levels are plotted as 0.
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Laboratory studies
In the acute phase after TBI, CSF hypocretin-1 levels were
undetectable in 13, low (5320 pg/ml) in 12, and normal in
2 patients. Six months later, undetectable levels were not
observed (Fig. 2). Levels remained low in four patients
(range 211–289 pg/ml; see later), and were normal in
17 patients. An increase (‘recovery’) of hypocretin-1 levels
between acute phase (79 103 pg/ml) and follow-up
(406 121 pg/ml) was observed in all patients, in whom
CSF was available at both time points (n¼ 15, P50.001).
Thyroid function was normal in all patients. Mild iron
deficiency was found in two, and mild anaemia in five
patients. HLA DQB10602 was positive in 12 (18%)
patients, and HLA DRB115 was positive in 9 (14%)
patients.
Identification of potential causes of
post-traumatic SWD
Forty-seven patients were diagnosed with post-traumatic
SWD (S-EDS: n¼ 18, O-EDS, n¼ 16, post-traumatic
hypersomnia: n¼ 14, fatigue: n¼ 11, insomnia: n¼ 3);
potential causes are summarized in Fig. 3. In 28
patients (43% of the study population), we could not
find a potential cause underlying post-traumatic SWD
(Table 3).
Identification of risk factors for
post-traumatic SWD
Sleep efficiency was significantly lower in patients 50 years
(P50.005). Apart from these differences, gender and age
did not influence the development of post-traumatic SWD.
Severe TBI was associated with the development of
post-traumatic hypersomnia (P¼ 0.02), but not with
the presence, characteristics and severity of other post-
traumatic sleep–wake disorders. Similarly, there were
no associations between severity of TBI as assessed by
CT scans and sleep outcome parameters. There were
no associations between localization of TBI and post-
traumatic SWD. Neurological and sleep-related outcome
in patients with visible lesions in the hypothalamus
or in the brainstem (n¼ 10) did not differ from other
patients.
Pathological findings in the neurological examination
6 months after TBI were not associated with post-traumatic
SWD. There were no associations between HLA typing,
initial CSF hypocretin levels and post-traumatic SWD.
However, significantly decreased CSF hypocretin-1 levels
were observed in EDS patients, compared to patients
without post-traumatic EDS, 6 months after TBI (Table 4).
Furthermore, low CSF hypocretin-1 levels 6 months after
TBI were associated with poorer clinical outcome as
assessed by GOS (Table 5).
Sleep^wake disturbances and quality of life
General outcome (GOS) was significantly worse in patients
with subjective EDS (P¼ 0.02). Similarly, there were
weak correlations between general health perception and
ESS (r ¼ –0.38, P¼ 0.04) and sleep efficiency on PSG
(r¼ 0.31, P¼ 0.03), respectively. There was, however, no
correlation between quality of life and MSLT findings.
Furthermore, there were no correlations between Beck
Depression Inventory scores and post-traumatic SWD.
Single patient reports
In two male patients (18 and 26 years old), MSLT revealed
2 SOREM’s and abnormally short mean sleep latencies
(6.3 and 2.9min, respectively). ESS scores were 13 and
9, respectively. In both patients, Ullanlinna and Swiss
Narcolepsy Scales were normal. Neither patient had
cataplexy-like episodes, hypnagogic hallucinations, or sleep
paralysis. CSF hypocretin-1 levels in the acute phase were
0% 20% 40% 60% 80% 100%
OSAS, BIISS, and depression OSAS
PLMS BIISS
Narcolepsy without cataplexy Depression
No other cause than TBI
All SWD
S-EDS
O-EDS
PH 
Fatigue
Insomnia 
1
1
1
1
3
2
3
4
4
1
3
1
2
2
2
2
1
1
6
2
1
1
28
10
10
9
7
Fig. 3 In 28 patients (43% of 65), we could not identify potential
causes other thanTBI underlying post-traumatic sleep^wake
disturbances (SWD). Forty-seven patients suffered from SWD
including S-EDS, O-EDS, PH, insomnia and/or fatigue (all SWD
group). S-EDS (subjective excessive daytime sleepiness, as assessed
by Epworth sleepiness scale 10) was observed in 18, O-EDS
(objective excessive daytime sleepiness, as assessed by mean sleep
latencies on MSLT55min) in 16, PH (post-traumatic hypersomnia:
increased sleep need per 24h 2h compared to pre-TBI
conditions) in 14, fatigue (tiredness, reported at interview,
withoutmeasures of EDS) in11and insomnia in 3 patients. For each
of these SWD, potential causes including OSAS (obstructive sleep
apnea syndrome: AHI410), PLMS (periodic limb movements at
sleep: PLMI415), BIISS (behaviourally induced insufficiency sleep
syndrome: difference in sleep time per 24h between weekdays
and weekends/holidays 2h), narcolepsy and depression, were
assessed.Other causes were not identified. Each bar represents
the total of patients with a specific post-traumatic SWD, and is
divided into the possible causes underlying the respective SWD.
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63 and 83 pg/ml. Six months after TBI, levels were normal
(468 pg/ml) and low (289 pg/ml), respectively. HLA typing
was negative for both patients. In the younger patient,
TBI was mild, but severe in the 26-year-old patient. Brain
CT scans did not reveal hypothalamic lesions. These
patients were asymptomatic before TBI. Based on the
MSLT findings and according to the international classifi-
cation of sleep disorders, these two patients can be
diagnosed as narcolepsy without cataplexy (American
Academy of Sleep Medicine, 2005).
One male patient (22 years old) reported hypnagogic
hallucinations and cataplexy-like episodes (subjective
weakness in both knees with laughter), which did not
fulfill the criteria of cataplexy (Anic-Labat et al., 1999).
ESS was 11, Ullanlinna Narcolepsy Scale 15, Swiss
Narcolepsy Scale normal, mean sleep latency 5.6min and
there were no SOREM’s. This patient with a narcolepsy-
cataplexy-like phenotype reported that he had not observed
these symptoms prior to TBI. CSF hypocretin-1 was low
6 months after TBI (225 pg/ml).
Table 3 Patients with post-traumatic hypersomnia (defined as increased sleep need per 24h  2h compared to pre-TBI
conditions) at 6 months afterTBI
Hypersomnia No hypersomnia P
n 14 51
Age (years) 3216 4217 0.07
Male gender 12 41 0.49y
GCS# 8 (7, 3^14) 11 (12, 3^15) 0.02
GOS# 5 (5, 4^5) 4 (4, 3^5) 0.04
Sleep hours/night 9.01.9 7.91.4 0.44
ESS# 8, 7, 3^16 8, 7, 2^20 0.94
PSG sleep efficiency (%) 90.0 6.6 90.59.0 0.86
PSG REM% 20 8 20 6 0.94
PSG NREM I% 118 116 0.83
PSG NREM II% 42 9 469 0.12
PSG NREM III/IV% 20 7 159 0.08
PSG apnea-hypopnea-index 5.416.2 5.218.9 0.95
PSG periodic limb mov. index 5.18.3 5.3 9.2 0.95
MSLT mean sleep latency (mins) 8.8 4.1 9.4 5.0 0.69
Initial CSF hypocretin-1 levels 124139 (n¼11) 58 73 (n¼16) 0.17
CSF hypocretin-1 levels at 6 months 467 97 (n¼ 7) 380117 (n¼14) 0.10
Actigraphy: ‘‘time asleep’’ (hours) 124 (n¼ 8) 8 2 (n¼18) 0.20
Note: : mean SD; #: mean, median, range; y: Chi square; GCS: Glasgow Coma Scale; GOS: Glasgow Outcome Scale; PSG:
Polysomnography; ESS: Epworth Sleepiness Scale; MSLT: Multiple Sleep LatencyTest; CSF: cerebrospinal fluid.
Table 4 Patients with S-EDS (ESS 10) and O-EDS (mean sleep latency on MSLT55min) compared to patients without both
S-EDS and O-EDS
S-EDS and O-EDS no S-EDS and no O-EDS P
n 9 40
Male gender 9 35 0.44y
Age (years) 3818 3815 0.94
GCS# 12 (13, 5^15) 10 (10, 3^15) 0.25
GOS# 4 (4, 4^5) 5 (5, 3^5) 0.32
History: sleep hours/night 7.31.1 8.01.3 0.18
PSG sleep efficiency (%) 935 8911 0.29
PSG REM% 22 7 195 0.21
PSG NREM I% 13 9 115 0.46
PSG NREM II% 5110 4410 0.79
PSG NREM III/IV% 1110 17 9 0.10
PSG apnea-hypopnea-index 9 20 5 4 0.21
PSG periodic limb mov. index 5 6 59 0.87
Initial CSF hypocretin-1 levels 9131 (n¼ 4) 96130 (n¼15) 0.95
CSF hypocretin-1 levels at 6 months 289 64 (n¼ 4) 444113 (n¼10) 0.05
Note: : mean SD;#: mean, median, range; y: Chi square; (for definitions, seeTable 1). S-EDS: subjective excessive daytime sleepiness;
O-EDS: objective excessive daytime sleepiness; GCS: Glasgow Coma Scale; GOS: Glasgow Outcome Scale; PSG: Polysomnography;
CSF: cerebrospinal fluid.
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There were two other patients with a low CSF
hypocretin-1 level 6 months after TBI (besides one patient
with narcolepsy, and one patient with a narcolepsy-like
phenotype, see earlier). In a 58-year-old patient (211 pg/
ml), PSG revealed a moderate sleep apnea syndrome
(apnea hypopnea index: 25/h), and a short mean sleep
latency on MSLT (2.5min). In a 19-year-old patient
(234 pg/ml), all findings were normal.
Seven patients in our study (six males, mean age 57 12
years) suffered from obstructive sleep-apnea syndrome,
which was severe (AHI 430/h) in three patients.
Restless legs syndrome was not diagnosed in any patient,
whereas periodic limb movement disorder was found in
six patients.
Discussion
General outcome after traumatic brain injury
In this prospective study, we found an overall mortality
of 16%, which is in line with predicted values based on CT
findings (Marshall classification) (Maas et al., 2005).
Compared to large clinical outcome studies of TBI patients,
however, the clinical outcome of our patients was
favourable (Choi et al., 1991; Narayan et al., 2002;
Doppenberg et al., 2004). Still, this good outcome may
bias our study; post-traumatic sleep–wake disturbances may
be even more frequent in patients with a worse outcome.
Frequency of sleep^wake disorders after
traumatic brain injury
We found that SWD are common after TBI. New SWD
subsequent to TBI were present in three out of four
patients, consistent with previous reports (Betaar et al.,
1986; Cohen et al., 1992). The most prevalent SWD were
EDS/fatigue (55%) and post-traumatic hypersomnia (22%),
but not insomnia or circadian sleep–wake disorders.
Assessment of new SWD after TBI was based on
retrospective information from patients about their sleep
before TBI. Given that such data may not be entirely
reliable, some of the pertinent findings of this study must
be interpreted with caution. Furthermore, the relatively
small number of patients (n¼ 65) only allows us to
draw preliminary conclusions concerning the prevalence
of post-traumatic SWD. But as a prospective study,
it allows us to estimate the frequency of post-traumatic
SWD in a general population for the first time.
A supportive feature of the study is the high proportion
of consecutive TBI patients participating in all aspects of
the study (86% of all surviving patients, who had not
moved to foreign countries).
Clinical characteristics and potential causes
of post-traumatic sleep^wake disorders
In our population, EDS (n¼ 25, 38%), hypersomnia
(n¼ 14, 22%) and fatigue (n¼ 11, 17%) were the most
prevalent SWDs following TBI. Subjective EDS, defined as
ESS 10, was found in 28%, which does not differ from the
frequency (35%) in a general population, as reported in a
recent study with 556 patients (Mignot et al., 2006).
The patients in our study were younger (mean: 37 years)
than those of this recent study (mean: 64 years) so that
direct comparisons between the two populations cannot be
made. In our study, objective EDS (defined as abnormally
short mean sleep latencies on MSLT, however, was almost
as prevalent (25%) as subjective EDS, compared to 1–6% in
a general population (Mignot et al., 2006). The finding of
highly prevalent EDS with short mean sleep latencies on
MSLT is in agreement with previous studies in TBI patients
(Masel et al., 2001; Rao and Rollings, 2002).
Compared to other studies, the prevalence of insomnia
(n¼ 3, 5%) in our population was remarkably low
(Guilleminault et al., 2000; Fichtenberg et al., 2002;
Parcell et al., 2006; Ouellet et al., 2006a). This discrepancy
in findings is not easily explained. It might be accounted
for by the favourable clinical outcome of our patients
(lower occurrence of pain and depression may enhance
sleep quality). Furthermore, as pointed out initially,
there are marked methodological differences between
previous studies (e.g. differences in the assessment of
insomnia, in intervals between TBI and examinations,
in focusing on specific SWD and in population character-
ization), resulting in unequivocal findings. The finding
Table 5 Outcome parameters in patients with low and in patients with normal CSF hypocretin-1 levels 6 months afterTBI
Hypocretin-1 low Hypocretin-1 normal P
n 4 17
GCS (mean, median, range) 8 (7, 6^13) 11 (11, 3^15) 0.21
GOS (mean, median, range) 4 (4, 3^4) 5 (5, 4^5) 0.011
Increased sleep need/24h (n) 1 4 0.89
ESS (mean, median, range) 8 (8, 4^11) 8 (6, 3^20) 0.92
PSG sleep efficiency (mean SD) 93.74.6 91.37.2 0.53
MSL (mean SD) 6.4 5.6 9.14.2 0.41
2 SOREM periods on MSLT (n) 1 2 0.49
Note: GCS: Glasgow Coma Scale; GOS: Glasgow Outcome Scale; PSG: Polysomnography; ESS: Epworth Sleepiness Scale; MSL/MSLT: Mean
sleep latency on Multiple Sleep LatencyTest; SOREM: sleep-onset REM sleep.
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of a low frequency of insomnia may, at least in parts, be
explained by an overestimation of insomnia symptoms in
questionnaire-based studies (Ouellet et al., 2006b).
Among patients with post-traumatic SWD, no common
clinical pattern could be identified (Fig. 3). In 19 patients,
we found potential causes of SWD other than TBI such as
obstructive sleep apnea, periodic limb movements at sleep,
behaviourally induced insufficiency sleep syndrome and
depression. There were, however, no associations between
EDS/fatigue/hypersomnia and depression (as assessed by the
Beck Depression Inventory). Restless legs syndrome was not
diagnosed in our patients (prevalence of 4–10% in the
normal population) (Tison et al., 2005). In two patients,
the criteria of narcolepsy without cataplexy (severe EDS, 2
SOREM’s on MSLT) were fulfilled. CSF hypocretin-1 level 6
months after TBI was low in one of these patients. Based on
the patients’ history, we assume that these symptoms were
not present before TBI. In one patient with a low CSF
hypocretin-1 level 6 months after TBI, a narcolepsy-
cataplexy-like phenotype was observed. Post-traumatic
narcolepsy-cataplexy, however, was not identified in our
patients. In 28 patients (43%), potential causes for SWD
other than TBI could not be identified. In other words,
post-traumatic EDS, fatigue or post-traumatic hypersomnia
appear to be directly related to the neuronal injury itself in
almost one of two study patients.
Predisposing factors for post-traumatic
sleep^wake disorders
Hypocretin
CSF hypocretin-1 levels were normal in most (17/21)
patients 6 months after TBI, but levels were lower in
patients with EDS. In agreement with this finding, Bassetti
and collaborators (2003) reported hypocretin deficiency in
one patient with post-traumatic hypersomnia. Ripley and
collaborators (2001) found a low hypocretin-1 level in one
TBI patient 7 months after trauma. Data on sleep and
wakefulness after TBI, however, were not reported. Belmont
and colleagues (2006) reported an association between post-
traumatic fatigue and insufficiency in the hypothalamic-
pituitary axis, suggesting hypothalamic dysfunction.
Furthermore, in our study, lower hypocretin-1 levels were
associated with a worse clinical outcome. Although we
tested hypocretin in only a subset of patients, we believe
that these findings support the hypothesis that hypocretin
deficiency may contribute to the development of post-
traumatic SWD.
Several mechanisms might explain the transient decrease
of CSF hypocretin-1 levels in the acute phase after TBI,
with subsequent ‘recovery’ of levels at retesting 6 months
later. Autopsy studies have shown necrosis, haemorrhage
or structural abnormalities in the hypothalamus in up to
2/3 of patients with TBI (Crompton, 1971; Benvenga et al.,
2000). Thus, TBI may damage hypocretin neurons or their
axons. If so, then recovery of hypocretin levels after TBI
would reflect adaptation by other hypocretin-producing
cells. In patients with increased sleep propensity after TBI,
hypocretin production of the remaining neurons may be
inadequate, resulting in residual low levels (Gerashchenko
et al., 2003; Scammell, in press). Thus, it is conceivable that
critical/insufficient adaptation by surviving hypocretin cells
might be involved in post-traumatic EDS/hypersomnia.
Another explanation of transient CSF hypocretin-1
deficiency in acute TBI would be a reduction in hypocretin
neuron activity without injury of the cells or their axons,
e.g. mediated by increased inhibition, decreased excitation,
or in relation to altered vigilance (sleep, coma) or to
impaired circadian waking drive. Hypocretin is wake-
promoting and there is evidence that sleep enhances
plasticity effects after brain damage (Stickgold et al., 2001;
Carmichael et al., 2002). It is therefore reasonable to
assume that downregulation of hypocretinergic activity may
have beneficial effects regarding functional outcome. In our
study, however, there were no associations between
hypocretin levels in the acute phase after TBI and outcome
parameters.
Other factors
We found an association between severe TBI (as assessed by
the Glasgow Coma Scale) and post-traumatic hypersomnia.
Otherwise, we could not identify predisposing factors
(‘risk factors’) for the development of post-traumatic
SWD. There were no associations between gender, localiza-
tion of TBI, residual neurological symptoms, overall clinical
outcome (as assessed by the Glasgow Outcome Scale), HLA
typing, specific sleep study findings and the development or
severity of post-traumatic SWD. In general, therefore,
our findings are in line with reports of previous studies
that also could not identify correlations between character-
istics of TBI and post-traumatic SWD (Lankford et al.,
1994; Guilleminault et al., 2000; Masel et al., 2001). Besides
the small number of patients, a major limitation of our
study, however, is that patients only received CT examina-
tions. High-resolution neuroimaging (such as magnetic
resonance imaging), allowing for a better localization and
characterization of cerebral lesions, was not available.
Post-traumatic sleep^wake disturbances
and depression
We could not find associations between Beck Depression
Inventory scores and the presence or severity of post-
traumatic SWD. In contrast, significantly more SWD were
reported by patients with mild TBI compared to patients
with severe TBI in a recent study with the Pittsburgh
Sleep Quality Index (Mahmood et al., 2004). This might
give rise to the assumption that—especially in mild TBI
patients—neuropsychiatric factors may trigger the develop-
ment of post-traumatic SWD. Our findings, however,
suggest that the development of post-traumatic sleep–wake
disorders in TBI patients cannot be explained only on the
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basis of underlying psychiatric disorders or other
‘functional’ factors. We have not performed extensive
psychiatric evaluations in our patients so we cannot rule
out a preponderance of psychiatric disturbances in patients
with post-traumatic SWD.
Post-traumatic sleep^wake disturbances
and quality of life
Quality of life was affected most by a loss of vitality
complaints (SF-36) whereas bodily pain, physical or
psychological problems were rated less limiting.
Emanuelson and colleagues (2003) also examined the
quality of life after TBI with the SF-36 questionnaire in a
Scandinavian population, and also found vitality given the
lowest rating. Our findings indicate that complaints about
sleep–wake disorders (and particularly EDS) significantly
affect quality of life and social functioning, and must be
taken seriously.
Conclusion
In this prospective study, we found a high frequency of
SWD following TBI, in particular post-traumatic EDS,
fatigue and hypersomnia. In at least 43% of patients, post-
traumatic SWD appeared to be directly related to the injury
itself. An involvement of the hypocretin system in the
pathophysiology of post-traumatic SWD appears possible.
However, we could not identify risk factors predisposing
towards the development of post-traumatic SWD.
Post-traumatic SWD significantly harm quality of life
and social functioning. Further studies are needed to
identify the underlying pathophysiology of post-traumatic
sleep–wake disorders (perhaps using functional imaging
and histopathological techniques). A better understanding
of the neuropathophysiology of TBI and post-traumatic
SWD should lead to better therapeutic strategies for these
patients.
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